- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/82 - AmidesImides in position 3
Patent holdings for IPC class C07D 213/82
Total number of patents in this class: 1063
10-year publication summary
|
100
|
101
|
76
|
75
|
65
|
76
|
55
|
66
|
63
|
33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
25 |
| Takeda Pharmaceutical Company Limited | 2713 |
25 |
| F. Hoffmann-La Roche AG | 7925 |
21 |
| Novartis AG | 10849 |
19 |
| Vertex Pharmaceuticals Incorporated | 1597 |
19 |
| Boehringer Ingelheim International GmbH | 4650 |
18 |
| Syngenta Participations AG | 1903 |
18 |
| Amgen Inc. | 4074 |
17 |
| The Johns Hopkins University | 5667 |
16 |
| BASF SE | 20933 |
14 |
| Genentech, Inc. | 3976 |
13 |
| Janssen Pharmaceutica N.V. | 3392 |
13 |
| Syngenta Crop Protection AG | 6054 |
11 |
| Bayer Cropscience AG | 2035 |
11 |
| AstraZeneca AB | 2909 |
10 |
| Sumitomo Chemical Company, Limited | 9046 |
9 |
| The General Hospital Corporation | 4733 |
8 |
| Astellas Pharma Inc. | 1088 |
8 |
| Daiichi Sankyo Company, Limited | 1869 |
8 |
| Gilead Sciences, Inc. | 2036 |
8 |
| Other owners | 772 |